H. Suttman

发表

Patient-reported outcomes following abiraterone acetate plus prednisone added to androgen deprivation therapy in patients with newly diagnosed metastatic castration-naive prostate cancer (LATITUDE): an international, randomised phase 3 trial.

B. Keam, K. Fizazi, G. Facchini, 2018, The Lancet. Oncology.